Breaking News

Aptar Pharma Launches First Metal-Free Nasal Spray Pump

Specifically designed for recyclability, APF Futurity is the company’s first highly recyclable nasal spray pump.

By: Kristin Brooks

Managing Editor, Contract Pharma

Aptar Pharma, part of AptarGroup, Inc., a global provider of drug delivery systems, services and active material science solutions, launched APF Futurity, its first metal-free, multidose nasal spray pump developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations.
 
Specifically designed for recyclability, APF Futurity is the company’s first highly recyclable nasal spray pump, having achieved a Class AA certification from cyclos-HTP for recycling streams in Europe.
 
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors, thereby minimizing separation efforts in recycling streams and supporting a higher quality of recyclates.
 
When used in combination with a high-density polyethylene (HDPE) or polypropylene (PP) container bottle, a product with the APF Futurity pump can be conveniently recycled as one piece when empty after use, with no need to separate or detach any parts or materials before disposal, a key user benefit.
 
APF Futurity is based on Aptar Pharma’s Advanced Preservative Free (APF) technology platform, and has been initially developed to deliver multidose nasal saline and comparable OTC formulations. The metal-free pump delivers precise and consistent dosing with soft actuation, with no trade-off on handling and performance.
 
“APF Futurity is a game-changing innovation for the nasal spray pump industry and I am proud of our design and engineering team for meeting the challenge of designing this metal-free nasal pump,” said Stefan Ritsche, President Global Market Development, Consumer Health Care, Aptar Pharma. “This is an important step in the transformation of our nasal spray portfolio to more sustainable solutions, and we look forward to bringing additional innovations of this kind to meet the need in the pharmaceutical industry.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters